While open-heart (surgical) aortic valve replacement is the gold standard treatment for severe aortic valve stenosis, there are patients who may not be able to undergo traditional surgery because of ...

Transcatheter Aortic Valve Replacement Market Report Highlights Based on the implantation procedure, the transfemoral segment held the largest market share of 53.6% in terms of revenue in 2022.

In patients with severe aortic stenosis, transfemoral transcatheter aortic valve replacement with a repositionable valve appears to yield a high rate of device success, no moderate or severe ...

IRVINE, Calif., June 15, 2021 (GLOBE NEWSWIRE) -- JenaValve Technology, Inc., developer, and manufacturer of a novel transcatheter aortic valve replacement (TAVR) system, is pleased to announce ...

IRVINE, Calif.--(BUSINESS WIRE)--JenaValve Technology, Inc., developer and manufacturer of the JenaValve Pericardial transcatheter aortic valve replacement (TAVR) system for the treatment of ...

Aortic stenosis affects more than 3% of adults 65 years of age or older. 1,2 Current guidelines include aortic-valve replacement as a class I recommendation for patients with symptomatic severe ...

The use of transcatheter aortic-valve replacement has been shown to reduce mortality among high-risk patients with aortic stenosis who are not candidates for surgical replacement. However, the two ...

CoreValve’s transcatheter, transfemoral aortic valve replacement product is a non-surgical alternative that offers the large number of high or prohibitive surgical-risk patients an opportunity ...

The cohort represented 4% of the 241 patients who underwent transcatheter aortic valve replacement at their institution between October 2006 and November 2010. Transfemoral the Predominant Approach.

Medtronic, the global leader in healthcare technology, today announced new data from the largest head-to-head comparative trial of transfemoral transcatheter aortic valve replacement (TAVR), the ...

Download this article's Factoid (PDF & PPT for Gold Subscribers) Less than half of inoperable patients undergoing transcatheter aortic valve replacement (TAVR) are eligible for the transfemoral ...